Universität zu Köln

Bauer, Peter, Hunimel, Michael, von Kalle, Christof, Schmutzler, Rita, Block, Andreas, Stroth, Matthias, Woopen, Christiane and Engelke, Karsten (2016). Molecular Genetic Diagnosis - What we do know about Machines? What we do want to know? Oncol. Res. Treat., 39. S. 3 - 25. BASEL: KARGER. ISSN 2296-5262

Schmalenberg, Harald, Al-Batran, Salah-Eddin, Pauligk, Claudia, Zander, Thomas, Reichart, Alexander, Lindig, Udo, Kleiss, Mathias, Mueller, Lothar, Bolling, Claus, Seufferlein, Thomas, Reichardt, Peter, Kullmann, Frank, Eschenburg, Henning, Schmittel, Alexander, Egger, Matthias, Block, Andreas and Goetze, Thorsten Oliver (2018). CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomach. J. Cancer Res. Clin. Oncol., 144 (3). S. 559 - 570. NEW YORK: SPRINGER. ISSN 1432-1335

Schmalenberg, Harald, Pauligk, Claudia, Zander, Thomas, Reichart, Alexander, Lindig, Udo, Kleiss, Mathias, Mueller, Lothar, Bolling, Claus, Seufferlein, Thomas, Reichardt, Peter, Kullmann, Frank, Eschenburg, Henning, Schmittel, Alexander, Egger, Matthias, Block, Andreas, Al-Batran, Salah-Eddin and Goetze, Thorsten Oliver (2017). A multicentre, phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the oesophagogastric junction and stomach (CABAGAST). J. Clin. Oncol., 35. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Vogel, Arndt, Kasper, Stefan ORCID: 0000-0002-5947-8733, Bitzer, Michael, Block, Andreas, Sinn, Marianne, Schulze-Bergkamen, Henning, Moehler, Markus, Pfarr, Nicole, Endris, Volker, Goeppert, Benjamin ORCID: 0000-0002-4135-9250, Merx, Kirsten, Schnoy, Elisabeth, Siveke, Jens T., Michl, Patrick, Waldschmidt, Dirk, Kuhlmann, Jan, Geissler, Michael, Kahl, Christoph, Evenkamp, Ralph, Schmidt, Torben, Kuhlmann, Alexander, Weichert, Wilko and Kubicka, Stefan (2018). PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO study. Eur. J. Cancer, 92. S. 11 - 20. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852